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Abstract
Objective: There is a high comorbidity of schizophre-
nia and obsessive-compulsory disorder (OCD) associ-
ated with more severe symptoms. Standard pharma-
cotherapy achieve symptom improvement in approxi-
matly 60% only.
Results: We report about a 48-old women treated for
depression which developed successively psychotic
symptoms (ideas of reference, psychotic worries), neg-
ative symptoms (blunted affect, impoverished think-
ing, difficulties in planning), and obsessive-compulsive
symptoms (mainly repeating rituals, avoidance behav-
iour, collecting and hoarding). She did not respond to
combined treatment with neuroleptics and high dose
selective serotonin re-uptake inhibitors. She acutely
improved during a course of electroconvulsive therapy
(ECT) and was maintained on outpatient ECTs fort-
nightly together with 12 mg sertindol and 45 mg mir-
tazapine for 42 weeks.
Conclusion: Maintenance ECT is not an approved
therapy in OCD but might be an option in pharma-
cotherapy refractory cases of comorbid OCD and
schizophrenic/schizoaffective disorder.
Key words: obsessive-compulsive disorder; schizophre-
nia; electroconvulsive therapy; atypical neuroleptics
INTRODUCTION
The frequency of obsessive and compulsive (OC)
symptoms in patients with schizophrenia is ranging
from 3.5% to 26% and is higher than in the general
population of less than 3%. Patients with comorbidity
of schizophrenia and obsessive-compulsive disorder
(OCD) were shown to have greater impairments in ex-
ecutive functions, vigilance, negative, and emotional
discomfort symptoms than those patients without OC
[1]. First line strategies in the treatment of OCD with
high-dose selective serotonin re-uptake inhibitors
(SSRI), venlafaxine, or clomipramine, and congnitive
behavioural therapy achieve symptom improvement in
approximatly 60% only. Up to date there are only a
few single case reports about electroconvulsive thera-
py (ECT) for comorbid OCD and schizophrenia [2, 3].
We report about a patient successfully treated with
maintenance ECT in comorbid OCD and unipolar
schizoaffective disorder.
CASE REPORT
The now 48-year old caucasian female nurse had been
in psychotherapeutic treatment for several years. She
was admitted to hospital for the first time at the age of
46 for a severe depressive episode treated with mir-
tazapine 45 mg. During the following weeks the pa-
tient developed psychotic symptoms as psychotic wor-
ries (debasement of her personality), helplessness, and
ideas of reference treated with 25 mg olanzapine, than
1400 mg quetiapine due to resistancy. Later on com-
pulsive symptoms occurred (repeated checking; pick-
ing up and collecting waste). Both schizodepressive
and compulsive symptoms were only partially remit-
ting under treatment with fluvoxamine 150 mg and
clozapine 400 mg at time of discharge. Negative
symptoms as difficulties in scheduling the day and
deficits in concentration, attention, and comprehen-
sion were persisiting. She was able to live independent-
ly, but could not return to her occupation.
Over the following months the patient’s OC symp-
toms, mainly compulsions, were exacerbating and
spreading. It included contamination obsessions (con-
fined to toilets), checking compulsions (checking lock-
ers and cooker several times, following other persons
or cars), repeating rituals (passing door- and stairways
several times or in a ritualised way, touching items sev-
eral times as door handles and handshaking), hoard-
ing/collecting compulsions (picking up things from
the street including waste and dog excrements, and
hoarding these items), and avoidance behaviour (re-
stricted to toilets). Before readmission it used to take
her up to 4 hours to leave the outpatients department
or home [Y-BOCS (Yale-Brown Obsessive Compulso-
ry Scale) score: 40, CGI (Clinical Global Impression)
severity score: 4]. Anxiety, blunted affect, thinking dis-
turbances, and impoverished thinking had increased.
Psychotic symptoms (see above) were relapsing.
PANSS (Negative and Negative Syndrome Scale)
showed a T-score and percentile equal to 99th per-
centile for negative syndromes, general psychopathol-
ogy, and the cluster activation and depression and
equal to 65th percentile for anergia. Combinations of
clozapine (up to 1000 mg) with amisulpride (400 mg),
and antidepressants (sertraline 200 mg) for two
months did not significantly improve OC and schizo-
phrenic symptoms.
August 12, 2009
Eur J Med Res (2009) 14: 367-368 © I. Holzapfel Publishers 2009
MAINTENANCE ELECTROCONVULSIVE THERAPY FOR
COMORBID PHARMACOTHERAPY-REFRACTORY OBSESSIVE-COMPULSIVE
AND SCHIZOAFFECTIVE DISORDER
F. Hanisch1,2, J. Friedemann1, J. Piro1, P. Gutmann1
1Klinik und Poliklinik für Psychiatrie, Psychotherapie und Psychosomatik, 2Klinik und Poliklinik für Neurologie,
Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Germany
7. Hanisch##:Umbruchvorlage  31.07.2009  11:58 Uhr  Seite 367After informed consent and discontinuation of all
oral medication the patient underwent 10 unilateral
ECT treatments administered twice a week with no
side effects. There was an immediate effect after the
first to two sessions leading to the short-term com-
plete remission of OC. Maintenance ECT was neces-
sary because follow-up after one month showed reoc-
currence of OC and schizophrenic symptoms (Y-
BOCS score: 25, CGI severity: 3, improvement: 5;
PANSS T-scores equal to 96th percentile for depres-
sion, and T-scores slightly above average for general
psychopathology and activation). Maintenance ECT
once in a fortnight in combination with 12 mg sertin-
dol and 45 mg mirtazapine resulted in stable remission
for 42 weeks (Y-BOCS score: 6, CGI severity: 1;
PANSS T-scores for all items within the average
range), which allowed her to live independently at
home but did not enable her to re-enter her previous
job or to start any other occupation due to passivity,
affect blunting, and some problems in problem solv-
ing.
DISCUSSION
There are only anecdotal reports of individual cases
[2, 3[ and a few open trials with case series [4, 5[ with
ECT in pharmacotherapy refractory OCD showing a
reduction of OC symptoms and a remission from one
to 12 months. As for other indications and as shown
in our case, maintenance ECT might be necessary in
refractory OCD [6, 7]. However, neither a placebo-
controlled (sham-controlled procedure) nor pharma-
cotherapy-controlled trial is available for ECT in
OCD. ECT has not received the approval of Food and
Drug Adinistration for the treatment of OCD.
More published data are available for ECT in schiz-
ophrenia [8] but scarcely for schizoaffective disorders.
The evidence of a Cochrane review suggested that
ECT is superior to placebo and medication alone in
patients with drug-resistant schizophrenia especially
when combined with antipsychotic drugs. However,
this initial beneficial effect may not last beyond the
short-term despite pharmacotherapy and maintenance
ECT therapy might be necessary. Substantial improve-
ment after ECT in schizophrenia patients treated with
clozapine persisted beyond 4 months in only 22.7%
[9].
It has been proposed that atypical antipsychotic
drugs like risperdone and olanzapine are highly benefi-
cial in augmentating the response to SSRIs for the
treatment of OCD [10]. However, it has also been
anaecdotecally reported that atypical neuroleptics
(clozapine, olanzapine, riperidone), when given as
monotherapy, have caused the symptoms of OCD to
appear or to worsen [11]. In retrospective studies the
number of newly occurring OCD under treatment
with clozapine was given with 2.4% - 21% and did
emerge with other atypical antipsychotics (olanzapine,
risperidone) in less than 2% [11]. In the present case
we cannot rule out that the OC symptoms were in-
duced and aggravated by atypical neuroleptics.
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